These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 28668717)

  • 1. Predictors of rapid high weight gain in schizophrenia: Longitudinal analysis of the French FACE-SZ cohort.
    Godin O; Leboyer M; Schürhoff F; Boyer L; Andrianarisoa M; Brunel L; Bulzacka E; Aouizerate B; Berna F; Capdevielle D; D'Amato T; Denizot H; Dubertret C; Dubreucq J; Faget C; Gabayet F; Llorca PM; Mallet J; Misdrahi D; Passerieux C; Rey R; Richieri R; Schandrin A; Urbach M; Vidailhet P; Costagliola D; Fond G;
    J Psychiatr Res; 2017 Nov; 94():62-69. PubMed ID: 28668717
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hypovitaminosis D is associated with depression and anxiety in schizophrenia: Results from the national FACE-SZ cohort.
    Fond G; Godin O; Schürhoff F; Berna F; Bulzacka E; Andrianarisoa M; Brunel L; Aouizerate B; Capdevielle D; Chereau I; Coulon N; D'Amato T; Dubertret C; Dubreucq J; Faget C; Lançon C; Leignier S; Mallet J; Misdrahi D; Passerieux C; Rey R; Schandrin A; Urbach M; Vidailhet P; Leboyer M; Boyer L; Llorca PM;
    Psychiatry Res; 2018 Dec; 270():104-110. PubMed ID: 30245372
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence of Metabolic Syndrome and Associated Factors in a Cohort of Individuals With Treatment-Resistant Depression: Results From the FACE-DR Study.
    Godin O; Bennabi D; Yrondi A; Richieri R; D'Amato T; Bellivier F; Bougerol T; Horn M; Camus V; Courtet P; Doumy O; Genty JB; El-Hage W; Haesebaert F; Holtzmann J; Lancon C; Leboyer M; Llorca PM; Maruani J; Molière F; Samalin L; Schmitt L; Stephan F; Vaiva G; Aouizerate MWB; Haffen E;
    J Clin Psychiatry; 2019 Oct; 80(6):. PubMed ID: 31617968
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Peripheral sub-inflammation is associated with antidepressant consumption in schizophrenia. Results from the multi-center FACE-SZ data set.
    Fond G; Godin O; Brunel L; Aouizerate B; Berna F; Bulzacka E; Capdevielle D; Chereau I; Dorey JM; Dubertret C; Dubreucq J; Faget C; Gabayet F; Le Strat Y; Micoulaud-Franchi JA; Misdrahi D; Rey R; Richieri R; Passerieux C; Schandrin A; Schürhoff F; Tronche AM; Urbach M; Vidalhet P; Llorca PM; Leboyer M;
    J Affect Disord; 2016 Feb; 191():209-15. PubMed ID: 26674214
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The 10-year findings from the FondaMental Academic Center of Expertise for Schizophrenia (FACE-SZ): Review and recommendations for clinical practice].
    Schürhoff F; Fond G; Berna F; Bulzacka E; Godin O; Boyer L; Misdrahi D; Andrianarisoa M; Brunel L; Coulon N; Aouizerate B; Capdevielle D; Chereau I; D'Amato T; Dubertret C; Dubreucq J; Faget C; Gabayet F; Mallet J; Rey R; Lancon C; Passerieux C; Schandrin A; Urbach M; Vidailhet P; Leboyer M; Llorca PM;
    Encephale; 2019 Feb; 45(1):9-14. PubMed ID: 30327207
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabolic Syndrome and Illness Severity Predict Relapse at 1-Year Follow-Up in Schizophrenia: The FACE-SZ Cohort.
    Godin O; Leboyer M; Schürhoff F; Llorca PM; Boyer L; Andre M; Andrianarisoa M; Aouizerate B; Berna F; Capdevielle D; Chereau I; Dorey JM; Dubertret C; Dubreucq J; Faget C; Lancon C; Leignier S; Mallet J; Misdrahi D; Passerieux C; Rey R; Roux P; Vidailhet P; Costagliola D; Fond G;
    J Clin Psychiatry; 2018 Sep; 79(6):. PubMed ID: 30257079
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metabolic syndrome in a French cohort of patients with bipolar disorder: results from the FACE-BD cohort.
    Godin O; Etain B; Henry C; Bougerol T; Courtet P; Mayliss L; Passerieux C; Azorin JM; Kahn JP; Gard S; Costagliola D; Leboyer M;
    J Clin Psychiatry; 2014 Oct; 75(10):1078-85; quiz 1085. PubMed ID: 25373115
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Early weight gain predicts later metabolic syndrome in depressed patients treated with antidepressants: Findings from the METADAP cohort.
    El Asmar K; Fève B; Colle R; Trabado S; Verstuyft C; Gressier F; Vievard A; Haffen E; Polosan M; Ferreri F; Falissard B; Chanson P; Becquemont L; Corruble E
    J Psychiatr Res; 2018 Dec; 107():120-127. PubMed ID: 30390577
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metabolic syndrome, abdominal obesity and hyperuricemia in schizophrenia: Results from the FACE-SZ cohort.
    Godin O; Leboyer M; Gaman A; Aouizerate B; Berna F; Brunel L; Capdevielle D; Chereau I; Dorey JM; Dubertret C; Dubreucq J; Faget C; Gabayet F; Le Strat Y; Llorca PM; Misdrahi D; Rey R; Richieri R; Passerieux C; Schandrin A; Schürhoff F; Urbach M; Vidalhet P; Girerd N; Fond G;
    Schizophr Res; 2015 Oct; 168(1-2):388-94. PubMed ID: 26255568
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Seasonal pattern in bipolar disorders and cardio-vascular risk factors: A study from the FACE-BD cohort.
    Geoffroy PA; Godin O; Mahee D; Henry C; Aubin V; Azorin JM; Bougerol T; Courtet P; Gard S; Kahn JP; Passerieux C; Leboyer M; Bellivier F; Etain B;
    Chronobiol Int; 2017; 34(7):845-854. PubMed ID: 28537802
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Confirmations, advances and recommendations for the daily care of schizophrenia based on the French national FACE-SZ cohort.
    Fond G; Godin O; Schürhoff F; Berna F; André M; Aouizerate B; Capdevielle D; Chereau I; D' Amato T; Dubertret C; Dubreucq J; Faget C; Lançon C; Leignier S; Mallet J; Misdrahi D; Passerieux C; Pignon B; Rey R; Szoke A; Urbach M; Vidailhet P; Leboyer M; Boyer L; Llorca PM;
    Prog Neuropsychopharmacol Biol Psychiatry; 2020 Jul; 101():109927. PubMed ID: 32173456
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Self-reported pain in patients with schizophrenia. Results from the national first-step FACE-SZ cohort.
    Fond G; Boyer L; Andrianarisoa M; Godin O; Bulzacka E; Berna F; Brunel L; Coulon N; Aouizerate B; Capdevielle D; Chereau I; D'amato T; Denizot H; Dubertret C; Dubreucq J; Faget C; Leignier S; Mallet J; Misdrahi D; Rey R; Lancon C; Passerieux C; Schandrin A; Urbach M; Vidailhet P; Leboyer M; Schurhoff F; Llorca PM;
    Prog Neuropsychopharmacol Biol Psychiatry; 2018 Jul; 85():62-68. PubMed ID: 29678770
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Depression trajectories and the association with metabolic adversities among the middle-aged adults.
    Kim EY; Kim SH; Ha K; Lee HJ; Yoon DH; Ahn YM
    J Affect Disord; 2015 Dec; 188():14-21. PubMed ID: 26340078
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence and predictors of metabolic syndrome in patients with schizophrenia and healthy controls: A study in rural South Indian population.
    Rawat VS; Ganesh S; Bijjal S; Shanivaram Reddy K; Agarwal V; Devi R; Kumar CN; Christopher R; Thirthalli J
    Schizophr Res; 2018 Feb; 192():102-107. PubMed ID: 28454923
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of metabolic syndrome and inflammation with neurocognition in patients with schizophrenia.
    Boyer L; Richieri R; Dassa D; Boucekine M; Fernandez J; Vaillant F; Padovani R; Auquier P; Lancon C
    Psychiatry Res; 2013 Dec; 210(2):381-6. PubMed ID: 23850204
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A two fold risk of metabolic syndrome in a sample of patients with schizophrenia: do consanguinity and family history increase risk?
    Bener A; Al-Hamaq AO; Dafeeah EE
    Diabetes Metab Syndr; 2014; 8(1):24-9. PubMed ID: 24661754
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A prospective, longitudinal study of metabolic syndrome in patients with bipolar disorder and schizophrenia.
    Malhotra N; Kulhara P; Chakrabarti S; Grover S
    J Affect Disord; 2013 Sep; 150(2):653-8. PubMed ID: 23608117
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Depression and major weight gain: a 6-year prospective follow-up of outpatients.
    Heiskanen TH; Koivumaa-Honkanen HT; Niskanen LK; Lehto SM; Honkalampi KM; Hintikka JJ; Viinamäki HT
    Compr Psychiatry; 2013 Aug; 54(6):599-604. PubMed ID: 23601988
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A 4-fold risk of metabolic syndrome in patients with schizophrenia: the Northern Finland 1966 Birth Cohort study.
    Saari KM; Lindeman SM; Viilo KM; Isohanni MK; Järvelin MR; Laurén LH; Savolainen MJ; Koponen HJ
    J Clin Psychiatry; 2005 May; 66(5):559-63. PubMed ID: 15889940
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sexual dysfunctions are associated with major depression, chronic inflammation and anticholinergic consumption in the real-world schizophrenia FACE-SZ national cohort.
    Fond G; Godin O; Dumontaud M; Faget C; Schürhoff F; Berna F; Aouizerate B; Capdevielle D; Chereau I; D'Amato T; Dubertret C; Dubreucq J; Leignier S; Mallet J; Misdrahi D; Passerieux C; Rey R; Schandrin A; Szoke A; Urbach M; Vidailhet P; Leboyer M; Lançon C; Boyer L; Llorca PM;
    Prog Neuropsychopharmacol Biol Psychiatry; 2019 Aug; 94():109654. PubMed ID: 31125587
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.